BUMETANIDE Drug Patent Profile
✉ Email this page to a colleague
When do Bumetanide patents expire, and what generic alternatives are available?
Bumetanide is a drug marketed by Gland Pharma Ltd, Hospira, MSN, Sagent, Teva Parenteral, West-ward Pharms Int, Amneal Pharms Co, Heritage Pharma, Rising, Sandoz, Taro, Upsher Smith Labs, and Zydus Pharms. and is included in fourteen NDAs.
The generic ingredient in BUMETANIDE is bumetanide. There are six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the bumetanide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bumetanide
A generic version of BUMETANIDE was approved as bumetanide by HOSPIRA on October 31st, 1994.
Summary for BUMETANIDE
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 14 |
| Finished Product Suppliers / Packagers: | 23 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Clinical Trials: | 28 |
| Patent Applications: | 4,067 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for BUMETANIDE |
| Drug Sales Revenues: | Drug sales revenues for BUMETANIDE |
| What excipients (inactive ingredients) are in BUMETANIDE? | BUMETANIDE excipients list |
| DailyMed Link: | BUMETANIDE at DailyMed |
See drug prices for BUMETANIDE
Recent Clinical Trials for BUMETANIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Yale University | Phase 1 |
| Jessa Hospital | Phase 4 |
| Vrije Universiteit Brussel | Phase 4 |
Pharmacology for BUMETANIDE
| Drug Class | Loop Diuretic |
| Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for BUMETANIDE
Anatomical Therapeutic Chemical (ATC) Classes for BUMETANIDE
US Patents and Regulatory Information for BUMETANIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms | BUMETANIDE | bumetanide | TABLET;ORAL | 202900-003 | Apr 30, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Gland Pharma Ltd | BUMETANIDE | bumetanide | INJECTABLE;INJECTION | 216434-001 | May 26, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sandoz | BUMETANIDE | bumetanide | TABLET;ORAL | 074700-002 | Nov 21, 1996 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Upsher Smith Labs | BUMETANIDE | bumetanide | TABLET;ORAL | 209916-002 | Jan 23, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| West-ward Pharms Int | BUMETANIDE | bumetanide | INJECTABLE;INJECTION | 079196-001 | Apr 30, 2008 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Msn | BUMETANIDE | bumetanide | INJECTABLE;INJECTION | 215364-001 | Aug 4, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Heritage Pharma | BUMETANIDE | bumetanide | TABLET;ORAL | 074225-002 | Apr 24, 1995 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
